Flubromazolam
Grundinformationen
- CAS
612526-40-6- Standard-SMILES
Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1F)=NC2- InChIKey
VXGSZBZQCBNUIP-UHFFFAOYSA-N- Summenformel
- C17H12BrFN4
- Durchschnittliche Molmasse
- 371,2 g/mol
- Monoisotopische Masse
- 370,0229367
Überblick
Flubromazolam is a DEA Schedule I controlled substance. Substances in the DEA Schedule I have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. It is a Depressants substance.
Namen und Bezeichner
- Bevorzugter Name
- Flubromazolam
- IUPAC
- 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
- Englischer Name
- FlubroMazolaM
- Summenformel
- C17H12BrFN4
- Molmasse
- 371.21
Namen und Synonyme
Flubromazolam612526-40-61BF1HN5GWD8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepineDEA NO. 2788DTXSID406202668-Bromo-1-methyl-6-(2-fluorophenyl)-4H-S-triazolo(4,3-a)(1,4)benzodiazepine4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-bromo-6-(2-fluorophenyl)-1-methyl-8-bromo-6-(2-fluorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine8-Bromo-1-methyl-6-(2-fluorophenyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepineRefChem:140801
Weitere Namen anzeigen
Flubromazolam (CRM)Top quality Flubromazolam 612526-40-six
DTXCID20571020998-867-1UNII-1BF1HN5GWD4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-bromo-6-(2-fluorophenyl)-1-methyl-; 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; 8-Bromo-1-methyl-6-(2-fluorophenyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepine; FlubromazolamSCHEMBL2841164SCHEMBL29858197VXGSZBZQCBNUIP-UHFFFAOYSA-NMZA52640
Datenbank-Bezeichner
- CAS
612526-40-6- PubChem CID
- 21930924
- DTXSID
DTXSID40620266- UNII
- 1BF1HN5GWD
- EC Number
- 998-867-1
- Nikkaji
- J3.465.798J
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2
- Polarare Oberfläche (TPSA)
- 43,1 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 23
- Formalladung
- 0
- Komplexität
- 474
Experimentelle und physikochemische Eigenschaften
Drugs
DEA NFLIS-Drug Category -> Benzodiazepines
DEA Schedule I Controlled Substance -> Depressants
Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds
Physikochemische Eigenschaften
- Siedepunkt
- 520.6 · 520.6±60.0 °C(Predicted)
- Dichte
- 1.6 · 1.60±0.1 g/cm3(Predicted)
- pka
- 2.27 · 2.27±0.40(Predicted)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P270, P271, P301+P317, P304+P340, P319, P330, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Gefahrenhinweise
Regulatory InformationDEA schedule I controlled substance
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Sicherheitsdaten
- Alarmwort
- Achtung
- Gefahrenhinweise
- Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H225
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological ClassificationDrugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Zugehörige Reaktionen
1
Notizen zur Verbindung
Wird geladen…